We Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for WE PHARMS, and what generic and branded alternatives to WE PHARMS drugs are available?
WE PHARMS has two approved drugs.
Drugs and US Patents for We Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
We Pharms | PREDNISOLONE SODIUM PHOSPHATE | prednisolone sodium phosphate | SOLUTION;ORAL | 075181-001 | Dec 23, 2002 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
We Pharms | PREDNISOLONE | prednisolone | SYRUP;ORAL | 040192-001 | May 28, 1998 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.